Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S T Davis

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Proceedings of the National Academy of Sciences of the United States of America|August 16, 1994
Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminaseB E Huber, E A Austin, C A Richards, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Dihydropyrimidine dehydrogenase inactivation and 5-fluorouracil pharmacokinetics: allometric scaling of animal data, pharmacokinetics and toxicodynamics of 5-fluorouracil in humansS P Khor, H Amyx, S T Davis, et al.
Cancer Research|December 15, 1995
5-Ethynyluracil (776C85): effects on the antitumor activity and pharmacokinetics of tegafur, a prodrug of 5-fluorouracilS Cao, D P Baccanari, S S Joyner, et al.
Journal of Medicinal Chemistry|April 11, 1997
Inhibition of uridine phosphorylase. Synthesis and structure-activity relationships of aryl-substituted 1-((2-hydroxyethoxy)methyl)-5-(3-phenoxybenzyl)uracilG F Orr, D L Musso, J L Kelley, et al.
Investigational New Drugs|November 18, 2000
Preclinical development of eniluracil: enhancing the therapeutic index and dosing convenience of 5-fluorouracilM T Paff, D P Baccanari, S T Davis, et al.
Biochemical Pharmacology|February 29, 2000
alpha-fluoro-beta-alanine: effects on the antitumor activity and toxicity of 5-fluorouracilS Cao, D P Baccanari, Y M Rustum, et al.
Journal of Medicinal Chemistry|September 15, 1995
Inhibition of uridine phosphorylase: synthesis and structure-activity relationships of aryl-substituted 5-benzyluracils and 1-[(2-hydroxyethoxy)methyl]-5-benzyluracilsG F Orr, D L Musso, G E Boswell, et al.
Journal of Medicinal Chemistry|December 1, 2001
Oxindole-based inhibitors of cyclin-dependent kinase 2 (CDK2): design, synthesis, enzymatic activities, and X-ray crystallographic analysisH N Bramson, J Corona, S T Davis, et al.
Science (New York, N.Y.)|January 6, 2001
Prevention of chemotherapy-induced alopecia in rats by CDK inhibitorsS T Davis, B G Benson, H N Bramson, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Proceedings of the National Academy of Sciences of the United States of America|August 16, 1994
Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminaseB E Huber, E A Austin, C A Richards, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Dihydropyrimidine dehydrogenase inactivation and 5-fluorouracil pharmacokinetics: allometric scaling of animal data, pharmacokinetics and toxicodynamics of 5-fluorouracil in humansS P Khor, H Amyx, S T Davis, et al.
Cancer Research|December 15, 1995
5-Ethynyluracil (776C85): effects on the antitumor activity and pharmacokinetics of tegafur, a prodrug of 5-fluorouracilS Cao, D P Baccanari, S S Joyner, et al.
Journal of Medicinal Chemistry|April 11, 1997
Inhibition of uridine phosphorylase. Synthesis and structure-activity relationships of aryl-substituted 1-((2-hydroxyethoxy)methyl)-5-(3-phenoxybenzyl)uracilG F Orr, D L Musso, J L Kelley, et al.
Investigational New Drugs|November 18, 2000
Preclinical development of eniluracil: enhancing the therapeutic index and dosing convenience of 5-fluorouracilM T Paff, D P Baccanari, S T Davis, et al.
Biochemical Pharmacology|February 29, 2000
alpha-fluoro-beta-alanine: effects on the antitumor activity and toxicity of 5-fluorouracilS Cao, D P Baccanari, Y M Rustum, et al.
Journal of Medicinal Chemistry|September 15, 1995
Inhibition of uridine phosphorylase: synthesis and structure-activity relationships of aryl-substituted 5-benzyluracils and 1-[(2-hydroxyethoxy)methyl]-5-benzyluracilsG F Orr, D L Musso, G E Boswell, et al.
Journal of Medicinal Chemistry|December 1, 2001
Oxindole-based inhibitors of cyclin-dependent kinase 2 (CDK2): design, synthesis, enzymatic activities, and X-ray crystallographic analysisH N Bramson, J Corona, S T Davis, et al.
Science (New York, N.Y.)|January 6, 2001
Prevention of chemotherapy-induced alopecia in rats by CDK inhibitorsS T Davis, B G Benson, H N Bramson, et al.
Pageof 2